Cardiovascular Therapeutics -Evidência and individualization

Code:

OPT112

Acronym:

TCEI

Keywords
Classification	Keyword
OFICIAL	Medicine

Instance: 2020/2021 - 1S (of 14-09-2020 to 07-02-2021)

Active?	Yes
Responsible unit:	Department of Medicine
Course/CS Responsible:	Integrated Master in Medicine

Cycles of Study/Courses

Acronym	No. of Students	Study Plan	Curricular Years	Credits UCN	Credits ECTS	Contact hours	Total Time
MIMED	39	Mestrado Integrado em Medicina- Plano oficial 2013 (Reforma Curricular)	5	-	3	28	81

Teaching language

Portuguese

Objectives

Medical doctors are in need of solid knowledge in the area of Therapeutics. Evidence is in constant shift, the same happening to recommendations. In this light, one of the pillars of this discipline consists in the study of therapeutic recommendations concerning common cardiovascular diseases. The second pillar of this discipline concerns the exceptions to the general rules, and aims at the study of circumstances that may lead to the fact that common recommendations cannot be followed.

Competences: The identification of the main sources of information regarding evidence on cardiovascular therapeutics; to be able to apply a set of recommendations and of therapeutic norms of particular importance in the treatment of common cardiovascular diseases; the identification of circumstances that may limit the application of frequently used norms, setting the stage for therapeutic individualization.

Learning outcomes and competences

Medical doctors are in need of solid knowledge in the area of Therapeutics. Evidence is in constant shift, the same happening to recommendations. In this light, one of the pillars of this discipline consists in the study of therapeutic recommendations concerning common cardiovascular diseases. The second pillar of this discipline concerns the exceptions to the general rules, and aims at the study of circumstances that may lead to the fact that common recommendations cannot be followed.

Competences: The identification of the main sources of information regarding evidence on cardiovascular therapeutics; to be able to apply a set of recommendations and of therapeutic norms of particular importance in the treatment of common cardiovascular diseases; the identification of circumstances that may limit the application of frequently used norms, setting the stage for therapeutic individualization.

Working method

Presencial

Program

Analysis of cardiovascular therapeutics, including the corresponding therapeutic recommendations in the following themes:

- Medical Therapeutics - general aspects/ Farmacogenetics.

- Arterial hypertension

- Dyslipidemia

- Diabetes mellitus (cardiovascular aspects)

- Stroke

- Angina pectoris

- Myocardial infarction / unstable angina

- Heart failure

- Atrial fibrillation

- Aortic valvular heart disease

- Bradyarrhyithmias - cardiac pacemakers, ICD, resynchronization.

Analysis of case reports in which the application of therapeutic recommendations is limited by co-morbidities or by other circumstances.

Mandatory literature

D.L. Kasper et al.; Harrison´s Principles of Internal Medicine, latest edition

Comments from the literature

American College of Cardiology http://www.acc.org/

European Society of Cardiology http://www.escardio.org/

Online encyclopedia “UpToDate”

Books (latest editions):

-               Harrison´s Principles of Internal Medicine

-               Hurst The Heart, McGraw Hill.

-               Braunwald Heart Disease, Saunders.

-               Goodman & Gilman The pharmacological basis of therapeutics, McGraw Hill.

Teaching methods and learning activities

The syllabus of the curricular unit encompass a broad range of cardiovascular diseases, including the most common ones, such as arterial hypertension, heart failure, angina pectoris and myocardial infarction. Through the analysis of therapeutics in these clinical conditions, as well as of the therapeutic guidelines, the student may reach the learning outcomes. It may be noted that the curricular content deals both with the general and with the particular case – both the disease and the patient - since, in the end of the day, each patient needs to be addressed as an autonomous entity, endowed with his/her own preferences.

Evaluation Type

Distributed evaluation with final exam

Assessment Components

Designation	Weight (%)
Apresentação/discussão de um trabalho científico	50,00
Exame	50,00
Total:	100,00

Amount of time allocated to each course unit

Designation	Time (hours)
Estudo autónomo	49,00
Frequência das aulas	22,00
Realização de Estágio	6,00
Trabalho escrito	4,00
Total:	81,00

Eligibility for exams

Presence in three quarters of the seminars and in at least one session in the clinic

Calculation formula of final grade

Writen work 50%; final exam 50%; students that do not present a written work are evaluated entirely by final exam (100%).